FDA panel endorses booster shot for J&J COVID-19 vaccine - Albuquerque Journal

FDA panel endorses booster shot for J&J COVID-19 vaccine

WASHINGTON — U.S. health advisers endorsed a booster of Johnson & Johnson’s COVID-19 vaccine Friday, citing concern that Americans who got the single-dose shot aren’t as protected as those given two-dose brands.

J&J told the Food and Drug Administration that an extra dose adds important protection as early as two months after initial vaccination — but that it might work better if people wait until six months later. Unable to settle the best timing, the FDA’s advisory panel voted unanimously that the booster should be offered at least two months after people got their earlier shot.

“I think this frankly was always a two-dose vaccine,” said FDA adviser Dr. Paul Offit of Children’s Hospital of Philadelphia. “It would be hard to recommend this as a single-dose vaccine at this point.”

The FDA isn’t bound by the recommendation as it makes a final decision — and adding to the debate’s complexity, new research also suggests that J&J recipients might have a stronger immune response if their booster dose is from a competing brand.

Preliminary results from an ongoing study of different ways to “mix and match” different shots showed that a booster of any sort revved up people’s levels of virus-fighting antibodies — at least for a few weeks. And the most dramatic jump came from giving a Pfizer or Moderna shot after the single-dose J&J vaccination.

FDA’s advisers didn’t vote on whether that should be recommended but told the government to allow flexibility with boosters, saying there were no safety red flags even if it’s not yet clear just how much difference, if any, mixing and matching may make in long-term protection.

“In the real world all these kind of combinations are already happening so I think it’s a matter of some urgency for the FDA to help sort out what is admittedly a complicated and challenging scenario,” said Dr. Ofer Levy of Boston Children’s Hospital.

The government says all three U.S. vaccines continue to offer strong protection against hospitalization and death from COVID-19, and that the priority is getting first shots to the 66 million eligible but unvaccinated Americans who are most at risk. But with the spread of the extra-contagious delta variant and signs of waning immunity against milder infections, the nation is moving toward a broader booster campaign.

Last month Pfizer boosters started being offered to seniors and younger adults at high risk from COVID-19 because of poor health, jobs or living conditions — at least six months after their initial vaccination. Thursday, the FDA advisory panel recommended the same approach for half-dose Moderna boosters.

But J&J’s vaccine has consistently shown lower effectiveness levels across a series of studies — and the FDA panel ultimately settled on another shot for any recipient 18 or older at least two months after their first vaccination.

“This is really — with the second dose — bringing it, I think, on par with those other vaccines in terms of effectiveness,” said Dr. Archana Chatterjee of Rosalind Franklin University.

The FDA will use its advisers’ recommendations to decide whether to authorize boosters for both J&J and Moderna. Next, the Centers for Disease Control and Prevention would rule on who should roll up their sleeves.

The vast majority of the 188 million Americans who are fully vaccinated against COVID-19 have received the Pfizer or Moderna options, while J&J recipients account for only about 15 million.

J&J’s vaccine is made with a different technology and on Friday, the company pitched its booster as a way to strengthen a robust vaccine that they said has retained its protective power over eight months. But FDA scientists pointedly challenged that assertion.

“There are data that suggest the effectiveness of this vaccine is actually less robust than the company’s presentation here,” said Dr. Peter Marks, FDA’s top vaccines official. “And that is a finding of concern particularly because that’s been seen in minority communities potentially and others.”

As for its booster, J&J presented results from a large study that found giving a second dose just two months after the first bumped protection against symptomatic COVID-19 to 94% from 70% in U.S. recipients. Giving that booster six months later instead prompted an even bigger jump in virus-fighting antibodies.

But in their own review, FDA scientists noted only a tiny portion of cases involved the delta variant, by far the dominant strain in the U.S. And while FDA’s reviewers found no new safety concerns about a second J&J dose, they noted other shortcomings. J&J followed booster recipients for little more than a month, making it hard to draw conclusions about the durability of protection. Also, FDA scientists stressed they hadn’t had time to independently confirm J&J’s data, which were submitted shortly before the meeting. That’s highly unusual and drew serious concern from the advisory panel.

The J&J vaccine was highly anticipated for its one-and-done formulation. But its rollout earlier this year was hurt by a series of troubles including manufacturing problems and some rare but serious side effects including a blood clot disorder and a neurological reaction called Guillain-Barre syndrome. In both cases, regulators decided the shot’s benefits outweighed those risks.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Home » Business » Health & Safety » FDA panel endorses booster shot for J&J COVID-19 vaccine


Albuquerque Journal and its reporters are committed to telling the stories of our community.

• Do you have a question you want someone to try to answer for you? Do you have a bright spot you want to share?
   We want to hear from you. Please email yourstory@abqjournal.com

taboola desktop

1
African scientists baffled by monkeypox cases in Europe, US
Health & Safety
Scientists who have monitored numerous outbreaks ... Scientists who have monitored numerous outbreaks of monkeypox in Africa say they are baffled by the disease's recent spread in Europe and North America. ...
2
2 New Mexico tribes closer to recreational cannabis sales
ABQnews Seeker
Two New Mexico tribes have signed ... Two New Mexico tribes have signed an agreement with state officials recognizing the tribe's authority to collect taxes on sales of cannabis products. The ...
3
A third of US should be considering masks, officials ...
ABQnews Seeker
COVID-19 cases are increasing in the ... COVID-19 cases are increasing in the United States -- and could get even worse over the coming months, federal health officials warned Wednesday in ...
4
A million empty spaces: Chronicling COVID's cruel US toll
Health & Safety
On the deadliest day of a ... On the deadliest day of a horrific week in April 2020, COVID took the lives of 816 people in New York City alone. Lost ...
5
Report: Trump officials, meat companies knew workers at risk
Health & Safety
During the first year of the ... During the first year of the COVID-19 pandemic, the meat processing industry worked closely with political appointees in the Trump administration to stave off ...
6
EU plan aims to help get wheat from Ukraine ...
Health & Safety
The European Commission proposed helping Ukraine ... The European Commission proposed helping Ukraine export its wheat and other grains by rail, road and river to get around a Russian blockade of ...
7
US overdose deaths hit record 107,000 last year, CDC ...
Health & Safety
More than 107,000 Americans died of ... More than 107,000 Americans died of drug overdoses last year, setting another tragic record in the nation's escalating overdose epidemic, the Centers for Disease ...
8
Pandemic gets tougher to track as COVID testing plunges
Health & Safety
Testing for COVID-19 has plummeted across ... Testing for COVID-19 has plummeted across the globe, making it much tougher for scientists to track the course of the pandemic and spot new, ...
9
Asian Games in China postponed because of spread of ...
ABQnews Seeker
Less than three months after Beijing ... Less than three months after Beijing hosted the Winter Olympics and Paralympics, the Olympic Council of Asia said Friday that this year's Asian Games ...